• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Michael Lee, Australia

    Michael Lee, Australia

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Willi Klein, UK

    Willi Klein, UK

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Mark Miller, UK

    Mark Miller, UK

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Zabun Nassar, England

    Zabun Nassar, England

  • Susan Keldani, USA

    Susan Keldani, USA

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Ian Gale, Australia

    Ian Gale, Australia

  • Jack Buzby, USA

    Jack Buzby, USA

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Steve

    Steve

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Alex, Argentina

    Alex, Argentina

  • David Solomon, UK

    David Solomon, UK

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Philip Brindle, England

    Philip Brindle, England

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Len Johnrose, England

    Len Johnrose, England

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login